Clinical trial
Evaluation of a Functional Lymphocyte Test (QuantiFERON Monitor®) as a Prognostic Marker for Acute Community-acquired Pneumonia
NCT03505281 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of a Functional Lymphocyte Test (QuantiFERON Monitor®) as a Prognostic Marker for Acute Community-acquired Pneumonia
- Lead sponsor
- Centre Hospitalier Universitaire Dijon
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 5, 2018
- Completion date
- July 30, 2025
- Enrollment
- 230 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.